Frequency Therapeutics, Inc. FREQ NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

42/100

2/7 Pass

SharesGrow Intrinsic Value

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Frequency Therapeutics, Inc. (FREQ) .

本頁證實的標準:

VALUE (100/100, 通過) — 分析師目標價暗示上行空間 (+367.3%).
分析師共識目標價 $1.40 (+367.3% 上行空間) — 華爾街分析師認為存在顯著上行潛力。

SharesGrow 綜合評分： 42/100 其中 2/7 項標準通過。

SharesGrow 7-Criteria Score

42/100

SG Score

View full scorecard →

✓

價值

100/100

Price-to-Earnings & upside

Proven by this page

未來

52/100

Analyst consensus

→ Forecast

✗

過去

0/100

→ Income

✓

健康

75/100

Debt-to-Equity & liquidity

→ Health

✗

護城河

0/100

→ Income

成長

58/100

→ Income

✗

收入

10/100

→ Income

估值概覽 — FREQ

估值倍數

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.44

EV/EBITDA0.0

每股數據

EPS (TTM)$-12.48

每股帳面價值$0.00

每股營收$0.68

每股自由現金流$0.00

收益率與內在價值

盈利收益率N/A

股息收益率0.00%

分析師目標價$1.40 (+367.3%)

EPS：實際 vs 預期

P/E Ratio & Earnings Yield

每股盈餘 (EPS) 歷史

Year	EPS（稀釋）	營收	淨利潤	淨利潤率
2017	$-1.68	$0.00	$-20.24M	-
2018	$-1.59	$0.00	$-19.17M	-
2019	$-0.52	$28.95M	$-16M	-55.3%
2020	$-0.82	$36.98M	$-26.51M	-71.7%
2021	$-2.47	$14.07M	$-84.69M	-602%
2022	$-2.33	$0.00	$-81.58M	-
2024	$-9.37	$2.27M	$-83.58M	-3680.4%
2025	$-12.48	$6.39M	$-117.26M	-1834.5%